9-37762069-G-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_144964.4(TRMT10B):c.138G>C(p.Glu46Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E46K) has been classified as Uncertain significance.
Frequency
Consequence
NM_144964.4 missense
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia type 1BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Illumina
- pontocerebellar hypoplasia type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000406 AC: 101AN: 249066 AF XY: 0.000370 show subpopulations
GnomAD4 exome AF: 0.000138 AC: 201AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727198 show subpopulations
GnomAD4 genome AF: 0.000203 AC: 31AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74502 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.138G>C (p.E46D) alteration is located in exon 2 (coding exon 1) of the TRMT10B gene. This alteration results from a G to C substitution at nucleotide position 138, causing the glutamic acid (E) at amino acid position 46 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at